Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model
Part of paid clinical trials in Stamford, Connecticut.
- Sponsor
- Fairtility
- Study ID
- NCT07017972
- Status
- Recruiting
Conditions
- Fertility Disorders
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- AI evaluation of embryos — DEVICEAI evaluation of embryos inside a time-lapse incubator.
Study Details
This protocol supports the reliable development and improvement of Artificial Intelligence (AI)-based applications by enabling training, verification, and validation using high-quality real clinical data. It also aims to enhance machine learning in developmental-use AI software. In addition, the professional user simulated use will ensure correct and easy use of the AI applications.
Key Dates
- Start date
- Jun 20, 2025
- Status verified
- Aug 2025
- Primary completion
- Jun 20, 2027
- Completion
- Jun 20, 2027
Study Design
- Enrollment
- 4,000 participants (estimated)
Primary Outcome Measure
Area under the curve (AUC) will be quantified using logistic regression to assess EQ Score's prediction of utilization. [ Time Frame: 7 days ]
Central Contacts
- Pedro Pini, M.D+541144704026
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| New England Fertility Institute | Stamford | Connecticut | 06905 |
Find similar trials in Stamford, CT
By research site
Related Studies
- Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.Recruiting · Fairtility · Scottsdale, Arizona